KR960706345A - 건선 치료(Psoriasis treatment) - Google Patents

건선 치료(Psoriasis treatment) Download PDF

Info

Publication number
KR960706345A
KR960706345A KR1019960703235A KR19960703235A KR960706345A KR 960706345 A KR960706345 A KR 960706345A KR 1019960703235 A KR1019960703235 A KR 1019960703235A KR 19960703235 A KR19960703235 A KR 19960703235A KR 960706345 A KR960706345 A KR 960706345A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
psoriasis
keratinous
dermatosis
topical treatment
Prior art date
Application number
KR1019960703235A
Other languages
English (en)
Other versions
KR100361240B1 (ko
Inventor
에이. 세퀘이라 조엘
에이. 처드리 임티어즈
에이. 피츠 에드윈
제이. 탄너 다니엘
엘. 테일러 유진
Original Assignee
에릭 에스. 딕커
쉐링 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에릭 에스. 딕커, 쉐링 코포레이션 filed Critical 에릭 에스. 딕커
Publication of KR960706345A publication Critical patent/KR960706345A/ko
Application granted granted Critical
Publication of KR100361240B1 publication Critical patent/KR100361240B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

본 발명은 약제학적으로 허용되는 비히클 내에 모메타손 푸로에이트(0.1%) 및 살리실산(5%)를 함유하는, 건선 및 이외의 각화성 및/또는 인설 피부병의 국소 치료를 위한 약제학적 조성물 및 이러한 약제학적 조성물을 사용하며 건선 및 각화성 인설 피부병을 치료하는 방법에 관한 것이다.

Description

건선 치료(Psoriasis treatment)
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 건선 및 이외의 각화성 및/또는 인설 피부병의 국소 치료에 유효한 약제학적 조성물의 제조를 위한 일정량의 모메타손 푸로에이트 및 살리실산의 용도.
  2. 하기의 성분을 포함하고, 건선 및 이외의 각화성 및/또는 인설 피부병의 국소 치료를 위한 연고 형태의 약제학적 조성물 :
  3. 제2항의 약제학적 조성물의 유효량을 국소 투여함을 포함하여 치료가 필요한 포유동물에서 건선 및 이외의 각화성 및/또는 인설 피부병을 치료하는 방법.
  4. 제2항에 있어서, 성분이 하기의 양으로 존재하는 약제학적 조성물 :
  5. 제4항의 약제학적 조성물의 유효량을 국소 투여함을 포함하여, 치료가 필요한 포유동물에서 건선 및 이외의 각화성 및/또는 인설 피부병을 치료하는 방법.
  6. 치료된 건선이 플라그-유형 심상성 건선인 제1항 내지 제5항 중의 어느 한 항에 따른 용도, 약제학적 조성물 또는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019960703235A 1993-12-21 1994-12-19 건선치료용약제학적조성물 KR100361240B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17105193A 1993-12-21 1993-12-21
US08/171,051 1993-12-21
US08/171051 1993-12-21

Publications (2)

Publication Number Publication Date
KR960706345A true KR960706345A (ko) 1996-12-09
KR100361240B1 KR100361240B1 (ko) 2003-01-29

Family

ID=22622295

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960703235A KR100361240B1 (ko) 1993-12-21 1994-12-19 건선치료용약제학적조성물

Country Status (22)

Country Link
EP (1) EP0735885B1 (ko)
JP (2) JP3830963B2 (ko)
KR (1) KR100361240B1 (ko)
CN (1) CN1055392C (ko)
AT (1) ATE271896T1 (ko)
AU (1) AU701833B2 (ko)
CA (1) CA2179628C (ko)
CZ (1) CZ283932B6 (ko)
DE (1) DE69433923T2 (ko)
ES (1) ES2221928T3 (ko)
FI (1) FI117001B (ko)
HK (1) HK1008814A1 (ko)
HU (1) HU226621B1 (ko)
IL (1) IL112019A (ko)
MY (1) MY111719A (ko)
NO (1) NO310854B1 (ko)
NZ (1) NZ278198A (ko)
PL (1) PL178427B1 (ko)
SK (1) SK280766B6 (ko)
TW (1) TW442281B (ko)
WO (1) WO1995017196A1 (ko)
ZA (1) ZA9410143B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19736265C2 (de) * 1997-08-15 2002-10-31 Phytexpert Pharm Tox Consultin Arzneimittel zur Behandlung von Hauterkrankungen
JP4101464B2 (ja) * 1998-08-26 2008-06-18 塩野義製薬株式会社 抗炎症軟膏剤
GR1006093B (el) * 2007-09-07 2008-10-06 Γεωργιος Καλλιμανης Παρασκευη φαρμακου με δραστικο συστατικο ουρσολικο οξυ (ursolic acid) για την θεραπεια ψωριασης
NZ591093A (en) * 2008-10-30 2012-02-24 Ego Pharmaceuticals Pty Ltd Anti-inflammatory pharmaceutical compositions comprising a corticosteroid, hexylene glycol and water
EP2394653A1 (en) 2010-05-26 2011-12-14 Almirall, S.A. Topical pharmaceutical compositions comprising mometasone furoate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4579844A (en) * 1976-05-13 1986-04-01 Johnson & Johnson Topical anti-inflammatory drug therapy
DE2744826A1 (de) * 1976-10-06 1978-04-13 Marques Brev Soc Et Exploit Therapeutische zubereitung
CY1359A (en) * 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
YU46838B (sh) * 1986-02-14 1994-06-24 Pero Dr. Višnjić Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles

Also Published As

Publication number Publication date
JP2005139210A (ja) 2005-06-02
IL112019A (en) 2000-02-17
CN1055392C (zh) 2000-08-16
EP0735885A1 (en) 1996-10-09
NZ278198A (en) 1997-12-19
FI962506A (fi) 1996-06-17
FI962506A0 (fi) 1996-06-17
CZ283932B6 (cs) 1998-07-15
SK81896A3 (en) 1997-04-09
HUT74460A (en) 1996-12-30
MY111719A (en) 2000-11-30
FI117001B (fi) 2006-05-15
NO962619D0 (no) 1996-06-20
CZ178496A3 (en) 1997-04-16
AU701833B2 (en) 1999-02-04
HU226621B1 (en) 2009-04-28
SK280766B6 (sk) 2000-07-11
NO962619L (no) 1996-06-20
JP3830963B2 (ja) 2006-10-11
WO1995017196A1 (en) 1995-06-29
DE69433923D1 (de) 2004-09-02
AU1432895A (en) 1995-07-10
CA2179628A1 (en) 1995-06-29
TW442281B (en) 2001-06-23
CN1138294A (zh) 1996-12-18
EP0735885B1 (en) 2004-07-28
ATE271896T1 (de) 2004-08-15
JPH09506897A (ja) 1997-07-08
IL112019A0 (en) 1995-03-15
ZA9410143B (en) 1995-06-20
NO310854B1 (no) 2001-09-10
DE69433923T2 (de) 2005-07-21
HK1008814A1 (en) 1999-05-21
ES2221928T3 (es) 2005-01-16
HU9601708D0 (en) 1996-08-28
PL315150A1 (en) 1996-10-14
KR100361240B1 (ko) 2003-01-29
PL178427B1 (pl) 2000-04-28
CA2179628C (en) 2000-10-24

Similar Documents

Publication Publication Date Title
US4997853A (en) Method and compositions utilizing capsaicin as an external analgesic
US3920835A (en) Treatment of disturbed keratinization
US3984566A (en) Method of alleviating the symptoms of dandruff
BR0015604A (pt) Método para o tratamento de cicatrizes hipertróficas de modo a reduzir o tamanho e/ou melhorar a aparência das mesmas, composições para tratar condições adversas da pele, e, para reduzir o tamanho e melhorar a aparência de cicatrizes hipertróficas
GB2394662A (en) Topical composition for treating pain
KR900017590A (ko) 좌창(Acne)치료방법 및 그 약제 조성물
KR970705990A (ko) 피부 질환 치료용 조성물(Compositions for the Treatment of Skin Disorders)
MX9603596A (es) Perfluoropolieteres o composiciones de los mismos para prevencion y tratamiento de infecciones virales topicas.
FI862609A0 (fi) Akne motverkande produkt.
BR9402089A (pt) Composição para cuidado da pele e processo para melhorar as propriedades de irritação provocada por retinol
PH31607A (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatosis.
KR960706345A (ko) 건선 치료(Psoriasis treatment)
KR970703142A (ko) 신전성 선조를 치료하기 위해 알파 히드록시산을 도포시키는 방법(applying alpha hydroxy acids for striae distensae)
KR890000093A (ko) 건선의 치료방법 및 치료용 조성물
US4994497A (en) Method of avoiding or minimizing burn damage to the skin
MX9203739A (es) Complejo organico de oro aplicado topicamente.
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
JPH09502737A (ja) 乾癬の外用治療用新規処法
DE3830333C1 (en) Pharmaceutical composition for the treatment of the eruption caused by herpes viruses
DE69434002D1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
ATE271872T1 (de) Topische carbamazepin-formulierungen und deren verwendung
JPH1160494A (ja) アトピー性皮膚炎再発防止剤
JPH01294635A (ja) 局所投与用製薬組成物
EP0095512B1 (en) Antipsoriatic composition
KR920702218A (ko) 피부 및 피하 조직에 대한 창상의 치료를 위한 라니티딘의 용도

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20131030

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20141030

Year of fee payment: 13

EXPY Expiration of term